Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Severin Schwan
AddedMar 31, 2024
UpdatedMay 31, 2026
Severin Schwan

Severin Schwan

Board Member, Genentech

Crunchbase

Severin Schwan's Career

Genentech
Genentech

South San Francisco, CA, US

Board Member· Board
Roche Holding
Roche Holding

Basel, Basel-Stadt, CH

Board Member· Board
Roche Venture Fund
Roche Venture Fund

Basel, Basel-Stadt, CH

CEO· C-Suite · Management
Credit Suisse First Boston
Credit Suisse First Boston

Zürich, Zürich, CH

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Severin Schwan's Career

Genentech
Genentech
Public13.5k1976South San Francisco, CA, US
Board Member· Board

Leadership at Genentech

Robert A. SwansonRobert A. SwansonCo-Founder
Herbert BoyerHerbert BoyerCo-Founder
Alexander HardyAlexander HardyCEO
Daniel O'DayDaniel O'DayBoard Member
Frederick KentzFrederick KentzBoard Member
Yuuta YamamotoYuuta YamamotoBoard Member
Roche Holding
Roche Holding
Public$7.8B103.6k1896Basel, Basel-Stadt, CH
Board Member· Board

Recent news

Gravitee, a platform that helps companies manage APIs, raises $60MTechCrunch · 2025
Healx, an AI-enabled drug discovery platform for rare diseases, raises $47MTechCrunch · 2024

Leadership at Roche Holding

Andreas OeriAndreas OeriBoard Member
Bernard PoussotBernard PoussotBoard Member
Fritz Hoffmann-La RocheFritz Hoffmann-La RocheFounder
Richard P. LiftonRichard P. LiftonBoard Member
Christoph FranzChristoph FranzBoard Member
Andre Serenus HoffmannAndre Serenus HoffmannBoard Member

Similar to Roche Holding

Memento MedicinesMemento MedicinesBoston, MA, USest. 2026Memento MedicinesBoston, MA, US · est. 2026

Memento Medicines is a Boston-based biotech developing biologic therapies for retinal diseases.

Series A · $93M
LonzaLonzaBasel, Basel-Stadt, CHBiotech, Pharmaceuticalsest. 1897LonzaBasel, Basel-Stadt, CH · est. 1897

Swiss-based Lonza, a global partner in pharmaceuticals, biotech, and nutrition, develops and commercializes medical treatments worldwide.

Public · $400M17.5k
BayerBayerLeverkusen, North Rhine-Westphalia, DEBiotechnology, Pharmaceuticalsest. 1863BayerLeverkusen, North Rhine-Westphalia, DE · est. 1863

Bayer AG: A leading global pharmaceutical and biotech company, offering healthcare and agricultural products.

Public · $3B101.4k
FerringFerringSaint-Prex, canton Vaud, CHPharmaceuticals, Treatmentsest. 1950FerringSaint-Prex, canton Vaud, CH · est. 1950

Ferring SAS: A Swiss-based global pharmaceutical firm specializing in diverse medical fields.

Public · $490M7k
Roche Venture Fund
Roche Venture Fund
Investment FirmInvestment Firm82002Basel, Basel-Stadt, CH
CEO· C-Suite · Management
Credit Suisse First Boston
Credit Suisse First Boston
Investment FirmInvestment Firm50.5k1996Zürich, Zürich, CH
Board Member· Board

Leadership at Credit Suisse First Boston

Keyu JinKeyu JinBoard Member
Seraina MaciaSeraina MaciaBoard Member
Mirko BianchiMirko BianchiBoard Member
António Horta-OsórioAntónio Horta-OsórioBoard Member
Clare BradyClare BradyBoard Member
Robert HurayRobert HurayBoard Member

Severin Schwan's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Severin Schwan

Heiner DreismannHeiner DreismannBoard Member · Myriad GeneticsUlrich AbshagenUlrich AbshagenBoard Member · Heidelberg InnovationSergio P. ErmottiSergio P. ErmottiBoard Member · Swiss ReVas NarasimhanVas NarasimhanBoard Member · AnthropicVeronica ScottiVeronica ScottiBoard Member · Swiss Re